Non-squamous histology but not adjuvant therapy affects survival in stage IB-IIA cervical cancer patients with intermediate risk following radical hysterectomy

被引:2
作者
Wang, Ying-Wen [1 ]
Lin, Hao [1 ]
Fu, Hung-Chun [1 ]
Chien, Chan-Chao Chang [1 ]
Ou, Yu-Che [2 ]
Lee, Pei-Hang [3 ]
Huang, Chao-Cheng [3 ]
Wu, Chen-Hsuan [1 ,4 ]
机构
[1] Kaohsiung Chang Gung Mem Hosp, Dept Obstet & Gynecol, Kaohsiung 833, Taiwan
[2] Chia Yi Chang Gung Mem Hosp, Dept Obstet & Gynecol, Chiayi 613, Chiayi County, Taiwan
[3] Kaohsiung Chang Gung Mem Hosp, Dept Anat Pathol, Kaohsiung 833, Taiwan
[4] Chang Gung Univ, Grad Inst Clin Med Sci, Taoyuan 333, Taiwan
关键词
Cervical cancer; Intermediate risk; Adjuvant treatment; PELVIC RADIATION-THERAPY; RANDOMIZED-TRIAL; CHEMOTHERAPY; CARCINOMA; CISPLATIN; SURGERY;
D O I
10.31083/j.ejgo4206175
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Objective: Radiotherapy is usually recommended following radical hysterectomy (RH) in early-stage cervical cancer with intermediate risk. However, adjuvant radiotherapy only decreases recurrence but not overall survival. This study aimed to compare different adjuvant modalities's efficacy and to identify prognostic factors among these patients. Methods: A single-center retrospective study was conducted between 2001 and 2015 on FIGO stage IB-IIA cervical cancer patients with intermediate risk following RH. 97 patients were enrolled for analysis. The patients underwent either RH and chemotherapy (n = 24), RH and radiotherapy (n = 21), or RH and close surveillance (n = 52). Prognostic factors that affected disease-free survival (DFS) and overall survival (OS), were compared by Kaplan-Meier analysis. Cox regression was used for univariate and multivariate analyses. Results: The median follow-up period was 117.7 months. There was no statistical difference between 5-year DFS and OS among patients receiving different adjuvant treatments, but patients with non-squamous histology had a lower 5-year DFS (p = 0.014). Multivariate analysis demonstrated no factors but only non-squamous histology significantly predicted DFS (HR = 3.565, 95% CI 1.334-9.531). Conclusions: Non-squamous histology, but not different adjuvant treatment, affects DFS in patients with stage IB-IIA cervical cancer with intermediate pathological risk following RH.
引用
收藏
页码:1205 / 1212
页数:8
相关论文
共 29 条
[1]   Intensity-modulated radiation therapy after hysterectomy: Comparison with conventional treatment and sensitivity of the normal-tissue-sparing effect to margin size [J].
Ahamad, A ;
D'Souza, W ;
Salehpour, M ;
Iyer, R ;
Tucker, SL ;
Jhingran, A ;
Eifel, PJ .
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2005, 62 (04) :1117-1124
[2]   Comparison of no adjuvant treatment and radiotherapy in early-stage cervical carcinoma with intermediate risk factors [J].
Akilli, Huseyin ;
Tohma, Yusuf A. ;
Bulut, Ayca N. ;
Karakas, Latife Atasoy ;
Haberal, Asuman N. ;
Kuscu, Ulku E. ;
Ayhan, Ali .
INTERNATIONAL JOURNAL OF GYNECOLOGY & OBSTETRICS, 2020, 149 (03) :298-302
[3]  
Bray F, 2018, CA-CANCER J CLIN, V68, P394, DOI [10.3322/caac.21492, 10.3322/caac.21609]
[4]   Randomized trial of neoadjuvant cisplatin, vincristine, bleomycin, and radical hysterectomy versus radiation therapy for bulky stage IB and IIA cervical cancer [J].
Chang, TC ;
Lai, CH ;
Hong, JH ;
Hsueh, S ;
Huang, KG ;
Chou, HH ;
Tseng, CJ ;
Tsai, CS ;
Chang, JT ;
Lin, CT ;
Chang, HH ;
Chao, PJ ;
Ng, KK ;
Tang, SGJ ;
Soong, YK .
JOURNAL OF CLINICAL ONCOLOGY, 2000, 18 (08) :1740-1747
[5]   Surgical treatment of "intermediate risk" lymph node negative cervical cancer patients without adjuvant radiotherapy-A retrospective cohort study and review of the literature [J].
Cibula, David ;
Abu-Rustum, Nadeem R. ;
Fischerova, Daniela ;
Pather, Selvan ;
Lavigne, Katie ;
Slama, Jiri ;
Alektiar, Kaled ;
Ming-Yin, Lin ;
Kocian, Roman ;
Germanova, Anna ;
Fruhauf, Filip ;
Dostalek, Lukas ;
Dusek, Ladislav ;
Narayan, Kailash .
GYNECOLOGIC ONCOLOGY, 2018, 151 (03) :438-443
[6]  
Grisaru D, 2001, CANCER, V92, P2999, DOI 10.1002/1097-0142(20011215)92:12<2999::AID-CNCR10145>3.0.CO
[7]  
2-1
[8]  
Health Promotion Administration Ministry of Health and Wel- fare, 2019, CERVICAL CANC SCREEN
[9]  
Health promotion administration Ministry of Health and Welfare Taiwan, 2018, cancer registry annual report
[10]   Treatment of cervical cancer with adjuvant chemotherapy versus adjuvant radiotherapy after radical hysterectomy and systematic lymphadenectomy [J].
Hosaka, Masayoshi ;
Watari, Hidemichi ;
Takeda, Mahito ;
Moriwaki, Masashi ;
Hara, Yoko ;
Todo, Yukiharu ;
Ebina, Yasuhiko ;
Sakuragi, Noriaki .
JOURNAL OF OBSTETRICS AND GYNAECOLOGY RESEARCH, 2008, 34 (04) :552-556